Title: "Seven Biotechs and Biopharmas Post Sizable IPOs in 2023 Despite Industry Drought"

Despite the challenging economic climate, the life science industry has witnessed a total of seven significant IPOs in 2023. However, when compared to previous years, it is clear that there is still a drought in IPO activity within the industry. In 2022, there were only 47 biotech IPOs, raising approximately $4 billion. This marks a significant decrease from 2021, which saw 152 offerings raising..